根据患者年龄预测患有血友病的患者血友性关节病的发展:一项回顾性单中心数据库研究
Radovan Kubeš1,2, Martin Stollin1,2, Štěpán Magersky1,2
1Department of Orthopaedics, First Faculty of Medicine, Charles University, Prague 8, Czech Republic.
Expert review of hematology
|November 28, 2023
概括
患有血友病 (PWH) 的患者在一生中会发生关节损伤. 这项研究估计了PWH中血友性关节病发病和关节置换手术的年龄.
科学领域:
- 整形外科 整形外科 整形外科
- 血液学 血液学 血液学
- 类风湿病学 类风湿病学
背景情况:
- 患有血友病 (PWH) 的患者容易出现复发性动脉,导致主要关节的血友性关节病.
- 了解关节病发病的年龄和随后的关节置换手术对于PWH管理至关重要.
研究的目的:
- 为了追溯估计血友病患者发展为血友性关节病的年龄.
- 为了确定PWH通常接受关节置换手术的年龄.
主要方法:
- 在捷克骨科中心对167个PWH的数据进行了回顾性分析.
- 卡普兰-梅尔分析被用来估计关节病和手术的累积比例作为年龄的函数.
主要成果:
- 血友性关节病发病的平均年龄:膝盖 (48),肘部 (51),脚 (52),部 (61),肩部 (>80).
- 大约80%的PWH在70岁时表现出关节损伤.
- 对于膝盖/关节置换,开始时间大约在50/60岁左右,手术发生在70/>75岁左右.
结论:
- 血友性关节病的风险在患者一生中不断积累.
- 这些发现允许对PWH关节病发育和关节置换手术的时间进行预测.
关键词:
年龄年龄年龄年龄年龄年龄关节质复原 关节质复原 关节质复原 关节质复原血友病 (hemophilia) 是一种血友病.血友性关节病 血友性关节病关节的改变 关节的改变整体内膜假体 整体内膜假体更多相关视频
09:51The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
2.6K
05:15Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
64
相关概念视频
01:09Changes in the Appendicular Skeleton with Age
The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...